Osteoblast-derived PTHrP is a physiological regulator of bone formation

被引:100
作者
Martin, TJ
机构
[1] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia
关键词
D O I
10.1172/JCI26239
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Parathyroid hormone-related protein (PTHrP) acts as a paracrine regulator in several tissues, and its physiological roles also extend to bone. In this issue of the JCI, Miao et al. demonstrate that osteoblast-specific ablation of Pthrp in mice results in osteoporosis and impaired bone formation both in vivo and ex vivo (see the related article beginning on page 2402). These mice recapitulate the phenotype of mice with haploinsufficiency of Pthrp. The findings demonstrate that PTHrP plays a central role in the physiological regulation of bone formation, by promoting recruitment and survival of osteoblasts, and probably plays a role in the physiological regulation of bone resorption, by enhancing osteoclast formation. This has implications for both our understanding of the pathogenesis of osteoporosis and its treatment.
引用
收藏
页码:2322 / 2324
页数:3
相关论文
共 22 条
[1]   Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development [J].
Amizuka, N ;
Karaplis, AC ;
Henderson, JE ;
Warshawsky, H ;
Lipman, ML ;
Matsuki, Y ;
Ejiri, S ;
Tanaka, M ;
Izumi, N ;
Ozawa, H ;
Goltzman, D .
DEVELOPMENTAL BIOLOGY, 1996, 175 (01) :166-176
[2]   EVIDENCE THAT INTERMITTENT TREATMENT WITH PARATHYROID-HORMONE INCREASES BONE-FORMATION IN ADULT-RATS BY ACTIVATION OF BONE LINING CELLS [J].
DOBNIG, H ;
TURNER, RT .
ENDOCRINOLOGY, 1995, 136 (08) :3632-3638
[3]   Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure [J].
Frolik, CA ;
Black, EC ;
Cain, RL ;
Satterwhite, JH ;
Brown-Augsburger, PL ;
Sato, M ;
Hock, JM .
BONE, 2003, 33 (03) :372-379
[4]   Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis [J].
Horwitz, MJ ;
Tedesco, MB ;
Gundberg, C ;
Garcia-Ocana, A ;
Stewart, AF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) :569-575
[5]   Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone [J].
Jilka, RL ;
Weinstein, RS ;
Bellido, T ;
Roberson, P ;
Parfitt, AM ;
Manolagas, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) :439-446
[6]   A G-PROTEIN LINKED RECEPTOR FOR PARATHYROID-HORMONE AND PARATHYROID-HORMONE RELATED PEPTIDE [J].
JUPPNER, H ;
ABOUSAMRA, AB ;
FREEMAN, M ;
KONG, XF ;
SCHIPANI, E ;
RICHARDS, J ;
KOLAKOWSKI, LF ;
HOCK, J ;
POTTS, JT ;
KRONENBERG, HM ;
SEGRE, GV .
SCIENCE, 1991, 254 (5034) :1024-1026
[7]   Temporal expression of PTHrP during endochondral bone formation in mouse and intramembranous bone formation in an in vivo rabbit model [J].
Kartsogiannis, V ;
Moseley, J ;
McKelvie, B ;
Chou, ST ;
Hards, DK ;
Ng, KW ;
Martin, TJ ;
Zhou, H .
BONE, 1997, 21 (05) :385-392
[8]   Importin β recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin α [J].
Lam, MHC ;
Briggs, LJ ;
Hu, W ;
Martin, TJ ;
Gillespie, MT ;
Jans, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7391-7398
[9]   PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth [J].
Lanske, B ;
Karaplis, AC ;
Lee, K ;
Luz, A ;
Vortkamp, A ;
Pirro, A ;
Karperien, M ;
Defize, LHK ;
Ho, C ;
Mulligan, RC ;
AbouSamra, AB ;
Juppner, H ;
Segre, GV ;
Kronenberg, HM .
SCIENCE, 1996, 273 (5275) :663-666
[10]   Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation [J].
Ma, YFL ;
Cain, RL ;
Halladay, DL ;
Yang, XH ;
Zeng, QQ ;
Miles, RR ;
Chandrasekhar, S ;
Martin, TJ ;
Onyia, JE .
ENDOCRINOLOGY, 2001, 142 (09) :4047-4054